THYROID CANCER 2009-2013 JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Slides:

Advertisements

Similar presentations

BREAST CANCER IN IDAHO This PowerPoint presentation was created as a collaborative effort among the Cancer Data Registry of Idaho/ Idaho.

Advertisements

Sylvia Le April 29, Disparities in Health Care Disparities in health care have serious impact on the quality of health care. Identifying health.

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

SEER PATTERNS OF CARE Kimberly Kimbler, MS, CCRP, CTR Kentucky Cancer Registry

Prostate Cancer Cancer: Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer.

How are cancer statistics kept up to date?.  Example:  Dx stage II colon cancer  Cancer has metastasized to the liver – 2009  How does the.

Basics of Pediatric Oncology Margret E. Merino, MD Pediatric Hematology/Oncology WRAMC.

Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

Session 1 (tutorial session): Radiation and Thyroid Cancer Summary Many patients with thyroid cancer were found in the Fukushima Health Management survey.

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.

Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.

Lung Cancer Emily Cauchon Katie Reeves Emily Cauchon Katie Reeves.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

CASEFINDING Debra W. Christie, MBA, RHIA, CTR, CCRP Director, Cancer Research & Data Center University of Mississippi Medical Center.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.

SEER Provided Data Mohammad Afnan Baqai 12/3/2009.

Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.

The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry

Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.

NCDB Report on Breast Cancer at Sibley Cancer Committee Feb Cancer Liaison Physician Karen Lisa Smith MD MPH.

HEAD/NECK CARCINOMA Johns Hopkins Hospital.

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

What does the data tell us? Colorectal CANCER IN NEVADA

NON-SMALL CELL LUNG CANCER

Cancer Reporting Changes for 2017 and 2018

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

Survival rates after thyroidectomy for papillary, mixed papillary-follicular, follicular, medullary, and undifferentiated thyroid cancer. Source: Thyroid.

Presented By Deborah Schrag at 2016 ASCO Annual Meeting

Johns Hopkins Hospital Malignant and Benign Brain/CNS

A graph of the 15-year survival curves comparing localized melanoma (Stages I and II), regional metastases (Stage III), and distant metastases (Stage IV).

JOHNS HOPKINS CANCER REGISTRY 2009

ANALYTIC PANCREATIC CANCER by CLASS N = 369

Johns Hopkins Hospital Cancer Registry

Shared Positive Affect Shared Negative Affect

6 Cancer survival Ontario Cancer Statistics 2018 Chapter 6: Cancer survival.

تهیه کننده: استاد مربوطه: بهار 1392

Estimated current cancer incidence

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Lung Cancer (C33-C34): Number and Proportion of Cases Diagnosed at Each Stage, Adults 15-99, Former Anglia Cancer Network Percentage of Total.

4155 primary hepatocellular carcinoma with known diagnosis month/year

Hypothesis Testing: Two-Sample Inference

National Cancer Statistics in Korea, 2015

Solving Equations 3x+7 –7 13 –7 =.

NAACCR/IACR Combined Annual Conference 2019

Lung Cancer (C33-C34): 2011 Proportion of Cases Diagnosed at Each Stage, Adults (Aged 15-99), England and Wales Stage Adults Stage I 14.5% Stage II 7.3%

Shared Positive Affect Shared Negative Affect

Presentation transcript:

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014

HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800 THYROID CANCER ALL CASES = 1717 ANALYTIC vs. NON-ANALYTIC

HEAD/NECK OF THE SKIN AGE AT DIAGNOSIS, ALL CASES N = 1800 THYROID CANCER ALL CASES = 1717 AGE AT DIAGNOSIS

THYROID CANCER ALL CASES = 1717 RACE/ETHNICITY

THYROID CANCER ALL CASES = 1717 STATE OF RESIDENCE AT DIAGNOSIS

THYROID CANCER ALL MARYLAND CASES = 1069 COUNTY OF RESIDENCE AT DIAGNOSIS

THYROID CANCER ANALYTIC CASES = 2828* AJCC STAGE *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

THYROID CANCER ANALYTIC CASES TREATMENT BY STAGE AJCC I (1149)AJCC II (88)AJCC III (168)AJCC IV (115) Surgery Only Surgery & Hormone Surgery, Radiation & Hormone Hormone Only Surgery & Radiation Other Combinations Not Treated % *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

THYROID CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

THYROID CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

THYROID CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT

THYROID CANCER 5-YEAR OBSERVED SURVIVAL JHH vs. SEER vs. NCDB ©2014 NCDB, CoC ©SEER; SEER*STAT